Metabolomics can distinguish ME/CFS patients from controls and identifies potentially important changed metabolites specific to ME/CFS, which is not found in Multiple Sclerosis patients


Dr Tiffany Lodge

Metabolic profiling in Healthy Controls,

ME/CFS and Multiple Sclerosis


James WL Strong

Metabolic profiling in Healthy Controls &



Professor James McCullagh

Analytical Chemistry

Director of the Mass Spectrometry Research Unit

Chemistry Department, University of Oxford

Print | Sitemap
© Morten, 2020